PathToScale: An Implementation Evaluation
Conditions: Oral Pre-exposure Prophylaxis (PrEP); Long-acting Injectable Cabotegravir for PrEP Interventions: Other: Standard intervention: Offer PrEP choice Sponsors: Georgetown University; AIDS Vaccine Advocacy Coalition; Centers for Disease Control and Prevention; Center for the Development of People; Cooper/Smith; Elizabeth Glaser Pediatric AIDS Foundation; Family Health Services; Healthqual; Johns Hopkins Research Project, Malawi; Johns Hopkins Bloomberg School of Public Health; Kamuzu University of Health Sciences; Blantyre District Health Office, Malawi; Lilongwe District Health Office, Malawi; Lighthouse Trust; Min...
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials
Viral Immunity in Solid Organ Transplant Recipients: Monitoring Of The Response To Hepatitis B Booster Vaccination
Conditions: HBV; Kidney Transplantation; Liver Transplantation Interventions: Drug: Tacrolimus; Drug: Belatacept Sponsors: University Hospital, Grenoble; National Agency for Research on AIDS and Viral Hepatitis (ANRS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in IGRA Positive Adolescents and Adults Living in a TB Endemic Region.
Conditions: Tuberculosis (TB) Interventions: Biological: MTBVAC; Biological: Placebo Sponsors: International AIDS Vaccine Initiative; Biofabri, SLU; Universidad de Zaragoza Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials
Therapeutic ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB
Conditions: Tuberculosis, Pulmonary Interventions: Biological: ID93 + GLA-SE vaccine; Biological: Placebo vaccine Sponsors: AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials
Solidarity/Tokomeza Ebola Trial
Condition: Sudan Ebola Virus Vaccines Interventions: Biological: CAd3; Biological: ChAdox1; Biological: rVSV-SUDV; Other: Control Sponsors: Makerere University; Makerere University Lung Institute; MRC/UVRI and LSHTM Uganda Research Unit; Makerere University Walter Reed Program; Epicentre; Uganda Virus Research Institute-International Aids Vaccine Initiative; Ministry of Health, Uganda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 19, 2023 Category: Research Source Type: clinical trials
